| Literature DB >> 25785191 |
Miltiadis K Tsilimbaris1, Aikaterini Chalkia1, Chrysanthi Tsika1, Anastasios Anastasakis1, Georgios A Kontadakis1.
Abstract
Purpose. To identify causes of incomplete visual recovery in patients with anatomically successful retinal detachment surgery. Methods. This was a retrospective study of 61 eyes of 61 patients with at least 12-month follow-up and complete preoperative, intraoperative, and postoperative record. Postoperative visual acuity (VA) more than 0.18 logMAR was considered as incomplete visual recovery. Complete ophthalmic examination and Spectral-Domain OCT (SD-OCT) imaging were performed at last follow-up. Results. Twenty-nine eyes (47.5%) had a postoperative VA < 0.18 logMAR and 32 eyes (52.5%) had a postoperative VA ≥ 0.18 logMAR. Mean follow-up was 32.8 ± 17.3 months. Incomplete visual recovery was strongly correlated with presence of macular pathology (P = 0.002), a detached macula preoperatively (P = 0.02), retinotomy (P = 0.025), and pars plana vitrectomy and use of silicon oil as a tamponade agent (P = 0.009). Also, although there was a strong correlation between ellipsoid zone disruption and incomplete visual recovery, a distinct, more course pathology could be identified in all cases of poor visual recovery related to edema, thickening, or atrophy of the macula. Conclusion. The careful postoperative evaluation of the macula using biomicroscopy and SD-OCT can help in diagnosis of alterations that can be associated with incomplete visual recovery.Entities:
Year: 2015 PMID: 25785191 PMCID: PMC4345258 DOI: 10.1155/2015/420401
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1SD-OCT image of a 63-year-old patient one year after anatomical repair of a macula-on RRD with 3PPV + SF6. We can notice the presence of CME, IS/OS (ellipsoid zone) disruption, and RPE changes.
Preoperative and postoperative parameters and comparisons between groups.
|
| Total (61) | Group A (29) | Group B (32) |
|
|---|---|---|---|---|
| Mean (SD) | ||||
| Age | 63 (11.1) | 61 (11.2) | 66 (10.6) | 0.09* |
| Preop. CDVA | 1.1 (1.08) | 0.75 (0.93) | 1.4 (1.1) | 0.015* |
| Postop. CDVA | 0.38 (0.52) | 0.07 (0.12) | 0.63 (0.54) | <0.0001* |
| Follow-up | 33 (17) | 31 (19) | 36 (16) | 0.46* |
| Postop. CFT | 353.7 (136.1) | 283 (66.6) | 419.4 (156.9) | 0.0002* |
|
| ||||
|
| ||||
| Macula off | 28 (46) | 9 (31) | 19 (59) | 0.03† |
| Anterior segment pathology | 9 (15) | 0 | 9 (28) | <0.0001† |
| Macular pathology | 34 (56) | 10 (34) | 24 (75) | 0.002† |
| ERM | 25 (41) | 9 (31) | 16 (50) | 0.12† |
| CME | 5 (8) | 0 | 5 (16) | |
| other | 4 (7) | 1 (3) | 3 (9) | |
| Ellipsoid zone disruption | 17 (28) | 1 (3) | 16 (50) | <0.0001† |
CDVA: corrected distance visual acuity, CFT: central foveal thickness, ERM: epiretinal membrane, and CME: cystoid macular edema.
* P value derived from independent samples t-test.
† P value derived from chi-squared test.